Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Acta Crystallographica. Section D, Biological Crystallography
|
December 14, 2006
Crystallization of protein-ligand complexes
Anne M Hassell, Gang An, Randy K Bledsoe, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 6, 2008
Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: potent inhibitors of the IGF-1R receptor tyrosine kinase
Stanley D Chamberlain, Joseph W Wilson, Felix Deanda, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2008
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity
Stanley D Chamberlain, Anikó M Redman, Joseph W Wilson, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 29, 2005
P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K
David G Barrett, Virginia M Boncek, John G Catalano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases
Edgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 23, 2008
Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)
Kyle A Emmitte, Brian J Wilson, Erich W Baum, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Acta Crystallographica. Section D, Biological Crystallography
|
December 14, 2006
Crystallization of protein-ligand complexes
Anne M Hassell, Gang An, Randy K Bledsoe, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 6, 2008
Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: potent inhibitors of the IGF-1R receptor tyrosine kinase
Stanley D Chamberlain, Joseph W Wilson, Felix Deanda, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2008
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity
Stanley D Chamberlain, Anikó M Redman, Joseph W Wilson, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 29, 2005
P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K
David G Barrett, Virginia M Boncek, John G Catalano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases
Edgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 23, 2008
Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)
Kyle A Emmitte, Brian J Wilson, Erich W Baum, et al.
Page
of 2